{"transactions":[{"id":1751173,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":108655,"kind":"person","name":"KAWAS LEEN","position":1,"cik":"0001822491","reported_name":"KAWAS LEEN","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-11-02T21:14:42.000Z","date":"2023-10-31","kind":"purchase","planned":false,"acquired":true,"shares":12345,"price":0.2615,"value":3228.2175,"ownership":{"direct":false,"nature":"See footnote."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Ms. Kawas controls Propel Bio Management LLC, a Delaware limited liability company (\"Propel Management\"). Ms. Kawas also shares control of Propel Bio Partners LLC, a Delaware limited liability company (\"Propel General Partner\"). Ms. Kawas, Propel Management and Propel General Partner act as the investment advisor to, or general partner of, or otherwise provide discretionary advisory services to, one or more private investment funds, and such investment funds acquired the referenced shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Ms. Kawas expressly disclaims beneficial ownership of the shares of Common Stock reported herein except to the extent of any pecuniary interest."}],"balance_after":4391432,"source":{"system":"sec-edgar","filing":"0001140361-23-051260","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000114036123051260/form4.xml","form_type":"4"}},{"id":1751172,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":108655,"kind":"person","name":"KAWAS LEEN","position":1,"cik":"0001822491","reported_name":"KAWAS LEEN","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-11-02T21:14:42.000Z","date":"2023-10-31","kind":"purchase","planned":false,"acquired":true,"shares":11987,"price":0.2625,"value":3146.5875,"ownership":{"direct":false,"nature":"See footnote."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Ms. Kawas controls Propel Bio Management LLC, a Delaware limited liability company (\"Propel Management\"). Ms. Kawas also shares control of Propel Bio Partners LLC, a Delaware limited liability company (\"Propel General Partner\"). Ms. Kawas, Propel Management and Propel General Partner act as the investment advisor to, or general partner of, or otherwise provide discretionary advisory services to, one or more private investment funds, and such investment funds acquired the referenced shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Ms. Kawas expressly disclaims beneficial ownership of the shares of Common Stock reported herein except to the extent of any pecuniary interest."}],"balance_after":4379087,"source":{"system":"sec-edgar","filing":"0001140361-23-051260","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000114036123051260/form4.xml","form_type":"4"}},{"id":2842638,"issuer":{"id":1487,"kind":"organization","name":"LeonaBio, Inc.","symbol":"LONA"},"owners":[{"id":108655,"kind":"person","name":"KAWAS LEEN","position":1,"cik":"0001822491","reported_name":"KAWAS LEEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-22T22:33:09.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":231000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth of the shares subject to the option will vest on January 8, 2022, and one-fourth of the shares subject to the option will vest on each year thereafter."}],"balance_after":231000,"derivative":{"exercise_price":21.15,"expiration_date":"2031-02-17","underlying":"Common Stock","underlying_shares":231000},"source":{"system":"sec-edgar","filing":"0001209191-21-012816","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620463/000120919121012816/doc4.xml","form_type":"4"}}]}